ZENG Jieming, M.D., Ph.D.

ZENG Jieming, M.D., Ph.D.

Dr. ZENG Jieming M.D., Ph.D. is a translational scientist with over two decades of benchwork experience, first author of 11 original research articles, scientific founder of CytoMed Therapeutics Limited, and inventor of both CytoMed’s CAR-γδ T cell and iPSC-γδ NKT cell technologies. He is now dedicated to translating these proprietary technologies into cell therapies for cancer treatment.

Speaker Articles

No items found.
Are you ready?

Get Early Access to
BioCon Asia-ACGT Conference!